Sprouts Launches Bold Lawsuit Challenging Insulin Pricing
Sprouts files lawsuit over insulin pricing scheme and PBM collusion.
By subject
Baird Medical Secures Pivotal Reimbursement Win for MWA
Successful reimbursement milestone strengthens device adoption and access strategy.
UK Government Unlocks Game-Changing Drug Pricing Strategy
UK braces as drug pricing shifts dramatically in market access landscape.
HAS Stroke Update Transforms Access on World Stroke Day
HAS strengthens stroke management for faster, equitable emergency care access.
Reimbursement Series: Anchors Affordable Breakthroughs – AIFA and TLV Expand European Coverage
Sweden expands reimbursement decisions driving biotech access and patient impact.
NICE Secures Breakthrough HTA Decision for Prostate Cancer
NICE issues breakthrough HTA decision on Bayer’s prostate cancer therapy.
NICE accelerates breakthrough framework for complex liver diseases
NICE drives innovation, reshaping MASH evaluations with transformative guidance.
Poland Makes Historic Leap in Healthcare: Record Number of New Therapies Now Reimbursed
Poland’s Ministry of Health has announced its largest-ever reimbursement list update
FDA’s BsUFA III Framework: What It Means for Biosimilar Sponsors
FDA defines biosimilar PAS & CBE under BsUFA III
Focus Brief: Market Access Weekly September 1 to 7, 2025
Global market access shifts: HTA speed, UK pricing, digital disruption.